-
The three giants dominate the $90 billion market, and the dominant position is firmly established
Time of Update: 2022-05-22
Whether globally or domestically, the diabetes drug market has always been led by three multinational giants, Novo Nordisk, Eli Lilly and Sanofi .
Whether globally or domestically, the diabetes drug market has always been led by three multinational giants, Novo Nordisk, Eli Lilly and Sanofi .
-
The first imitation of large varieties was approved intensively, and who is the first among Chia Tai Tianqing, Hengrui, Qilu and Yangzijiang
Time of Update: 2022-05-22
With the shift of business focus to innovative drugs, leading companies such as Chia Tai Tianqing, Hengrui, and Qilu are still in the forefront in the number of first copy approvals .
-
Double Anti-New Deal for comments!
Time of Update: 2022-05-22
At the end of March, its bispecific antibody targeting both tumor antigen B7H4 and T cell costimulatory molecule 4-1BB was approved for clinical application in China, which is a typical development logic of "small but beautiful" .
-
Generic pharmaceutical companies have a low success rate in transformation?
Time of Update: 2022-05-22
The difficulty in this is that if the BD of a generic drug company has no experience in innovative drug research and development, it is difficult to identify the "pit" of the project, including but not limited to animal experiments that do not support the drug entering the clinical stage at all, or the introduction of foreign products into the domestic market.
-
"Regulations on the Administration of Drug Annual Reports" will come into effect on April 12
Time of Update: 2022-05-22
According to the requirements of the "Drug Administration Law", drug marketing license holders shall establish an annual reporting system, and report the production and sales of drugs, post-marketing research, and risk management to the drug regulatory department in accordance with regulations .
-
The "14th Five-Year Plan" for the development of traditional Chinese medicine is promulgated, which is beneficial to the six categories of traditional Chinese medicinal materials!
Time of Update: 2022-05-22
This is the first five-year plan for traditional Chinese medicine issued in the name of the General Office of the State Council in accordance with the country's "Fourteenth Five-Year Plan for National Economic and Social Development and Outline of Vision 2035".
-
2022 National Drug Regulatory Policies and Regulations Work Conference Held
Time of Update: 2022-05-22
Strengthen the publicity and implementation of the "two high" judicial interpretations, actively promote the improvement of the working mechanism for the connection of executions, continuously increase the supervision of case investigation and handling, and give full play to the role of administrative reconsideration litigation and law enforcement supervision .
-
24.6 yuan down to 0.84 yuan!
Time of Update: 2022-05-22
However, at present, the province's designated retail pharmacies for medical insurance have not been included in the scope of centralized procurement, resulting in the out-of-hospital market supply of most winning varieties or the supply price being significantly higher than the winning price.
-
Innovent Bio won the 7th blockbuster variety and 25 innovative drugs exposed
Time of Update: 2022-05-22
Recently, good news of Innovent Bio has been frequently reported: Pemetinib tablets were approved in mainland China, Lilly ramucirumab was introduced, and revenue in 2021 exceeded 4 billion yuan.
-
Renfu $1.4 million and domestic sales of ANDA products soared
Time of Update: 2022-05-22
On April 9, Renfu Pharmaceutical announced that its holding subsidiary Yichang Renfu Pharmaceutical received the FDA approval number for ibuprofen tablets, which means that the product can be produced and sold in the US market .
-
6 chain pharmacies were cancelled, of which Yifeng Pharmacy acquired two
Time of Update: 2022-05-19
The announcement pointed out that in accordance with the relevant regulations and the application of the enterprise, it was decided to cancel the "Drug Business License" of Wuhan Yifeng Jianghan Pharmacy Chain Co.
-
The drug administration recommends stockpiling prevention and control drugs in some pharmacies: powerless
Time of Update: 2022-05-19
In response to the epidemic and related drug management work, the "Notice" emphasizes three aspects - drug quality and safety, drug market order, and recommends that pharmacies make appropriate preliminary reserves .
-
Will the HPV vaccine be given only one dose in the future?
Time of Update: 2022-05-19
During the live broadcast, Qiao Youlin, a professor at the School of Medicine and Public Health of Peking Union Medical College and a member of the WHO Global Cervical Cancer Elimination Expert Group, made a popular science on the topic of HPV preventive vaccination and cervical cancer prevention .
-
Pharmacy service fee is coming!
Time of Update: 2022-05-19
"Additional charges" for drug treatment outpatient clinics are limited to provincial public hospitals, and do not include charges for traditional Chinese medicine: Pharmacy service charges refer to the application of professional pharmacy knowledge and technology by clinical pharmacists who meet the prescribed qualifications in medical institutions to promote rationality and economy.
-
R&D investment continues to grow, pharmaceutical innovation seeks steady progress
Time of Update: 2022-05-19
In the future, funds from the government, enterprises, and capital markets will continue to be invested in the research and development of innovative drugs .
-
90% gross profit margin pharmaceutical companies appear!
Time of Update: 2022-05-19
In addition, the Central Commission for Discipline Inspection recently issued a document that it is necessary to close the market entrance and resolutely prevent the disorderly expansion of capital .
-
The health and health commission's rectification storm is coming!
Time of Update: 2022-05-19
Key point 6: Strictly prohibit excessive charges for nucleic acid testing The "Plan" will focus on in-depth special actions against crimes involving new coronary pneumonia vaccines in medical institutions at all levels and various types, and severely crack down on the production and sale of counterfeit products, illegal operations, smuggling, and vaccination in the field of vaccines in accordance with the law.
-
This type of pharmacy requires a 3-year medical insurance qualification with a licensed pharmacist!
Time of Update: 2022-05-19
Taking Hebei's "Draft" as an example, designated pharmacies should have a complete medical insurance settlement system and an invoicing system for outpatient co-ordination, realize electronic prescription circulation, and upload medical insurance settlement fees and invoicing and storage in a true, comprehensive, accurate and real-time manner.
-
The State Food and Drug Administration announced 116 medical device industry standard formulation and revision plans in 2022
Time of Update: 2022-05-19
In the project selection work, after public consultation and expert demonstration, 116 medical device industry standard formulation and revision plan projects in 2022 have been determined, which are hereby announced .
2022 medical device recommended industry standard formulation and revision plan project
-
WHO clarifies that one dose of HPV vaccine can cause Zhifei Bio to plummet
Time of Update: 2022-05-19
8 billion yuan; Wantai Biology reported 256.
However, the new SAGE recommendations are based on concerns about the slow introduction of the HPV vaccine into immunization programmes and low overall population coverage, especially in poorer countries .
